← Open Payments lookup

DIANE QUINTANA: Open Payments

NPI 1104430982 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,211 in 195 payments from 15 companies in 2025. Trend: 2023 $687 · 2024 $2,965 · 2025 $4,211

Food & beverage: $3,611Speaker / faculty: $600
CompanyPaymentsAmount
ABBVIE INC.38$1,186
Otsuka America Pharmaceutical, Inc.26$426
Alkermes, Inc.32$398
E.R. Squibb & Sons, L.L.C.15$382
Corium, LLC18$380
Axsome Therapeutics, Inc.14$307
Teva Pharmaceuticals USA, Inc.13$238
Supernus Pharmaceuticals, Inc.5$210
Takeda Pharmaceuticals U.S.A., Inc.8$200
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$198

Products named: VRAYLAR, REXULTI, COBENFY, Azstarys, ARISTADA, Auvelity, Qelbree, TRINTELLIX.

Industry payments across TX — which companies pay providers there.